Symbols / NTLA $13.87 +2.36% Intellia Therapeutics, Inc.

Healthcare • Biotechnology • United States • NGM
NTLA Chart
About

Intellia Therapeutics, Inc., a clinical-stage gene editing company, focuses on the development of curative genome editing treatments. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 that is in Phase 1/2 study for the treatment of hereditary angioedema. The company has license and collaboration agreement with AvenCell Therapeutics, Inc. to develop allogeneic universal CAR-T cell therapies; Kyverna Therapeutics, Inc. for the development of an allogeneic CD19 CAR-T cell therapy for the treatment of various of B cell-mediated autoimmune diseases; ONK Therapeutics, Ltd. for the development of engineered NK cell therapies to cure patients with cancer; and ReCode Therapeutics, Inc. to develop novel genomic medicines for the treatment of cystic fibrosis. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 1.64B
Enterprise Value 1.28B Income -412.69M Sales 67.67M
Book/sh 5.77 Cash/sh 3.81 Dividend Yield —
Payout 0.00% Employees 377 IPO —
P/E — Forward P/E -4.75 PEG —
P/S 24.21 P/B 2.40 P/C —
EV/EBITDA -2.97 EV/Sales 18.94 Quick Ratio 4.42
Current Ratio 5.08 Debt/Eq 13.90 LT Debt/Eq —
EPS (ttm) -3.81 EPS next Y -2.92 EPS Growth —
Revenue Growth 78.80% Earnings 2026-05-07 ROA -27.11%
ROE -53.48% ROIC — Gross Margin 0.00%
Oper. Margin -4.29% Profit Margin 0.00% Shs Outstand 118.13M
Shs Float 111.94M Short Float 37.37% Short Ratio 9.89
Short Interest — 52W High 28.25 52W Low 5.97
Beta 1.99 Avg Volume 4.79M Volume 3.01M
Target Price $25.29 Recom Buy Prev Close $13.55
Price $13.87 Change 2.36%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$25.29
Mean price target
2. Current target
$13.87
Latest analyst target
3. DCF / Fair value
$-35.55
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$13.87
Low
$5.00
High
$106.00
Mean
$25.29

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-04 up Jones Trading Hold → Buy $29
2026-03-03 main Canaccord Genuity Buy → Buy $48
2026-03-03 main Leerink Partners Outperform → Outperform $29
2026-03-03 main RBC Capital Sector Perform → Sector Perform $15
2026-03-03 main Wells Fargo Equal-Weight → Equal-Weight $15
2026-03-03 main Citizens Market Outperform → Market Outperform $28
2026-03-03 main HC Wainwright & Co. Buy → Buy $30
2026-03-02 main Chardan Capital Buy → Buy $27
2026-02-27 main Chardan Capital Buy → Buy $26
2026-01-28 main HC Wainwright & Co. Buy → Buy $25
2025-11-12 down Wolfe Research Outperform → Peer Perform —
2025-11-11 down Jones Trading Buy → Hold —
2025-11-11 down Evercore ISI Group Outperform → In-Line $8
2025-11-10 reit Truist Securities Buy → Buy $14
2025-11-10 main HC Wainwright & Co. Buy → Buy $15
2025-11-07 main Chardan Capital Buy → Buy $26
2025-11-07 main RBC Capital Sector Perform → Sector Perform $9
2025-11-07 main Wells Fargo Equal-Weight → Equal-Weight $12
2025-11-07 main Barclays Overweight → Overweight $14
2025-11-07 main Wedbush Neutral → Neutral $7
News
RSS: Latest NTLA news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-02 BASTA JAMES EDMUND General Counsel — 1,211 $13.78 $16,688
2026-03-02 CLARK ELIANA Chief Technology Officer — 607 $13.78 $8,364
2026-02-27 LEONARD JOHN M Chief Executive Officer — 156,400 $0.00 $0
2026-02-27 BASTA JAMES EDMUND General Counsel — 46,080 $0.00 $0
2026-02-27 LEBWOHL DAVID Officer — 9,943 $0.00 $0
2026-02-27 DULAC EDWARD J III Chief Financial Officer — 61,280 $0.00 $0
2026-02-27 CLARK ELIANA Chief Technology Officer — 7,353 $0.00 $0
2026-02-27 DUBE MICHAEL P Officer — 17,250 $0.00 $0
2026-02-27 SCHULTES BIRGIT C PH.D. Officer — 39,200 $0.00 $0
2026-01-05 COHEN FREDERICK E. M.D. PH.D. Director — 150,000 $9.35 $1,402,500
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
67.67
+16.92%
57.88
+59.55%
36.27
-30.40%
52.12
Operating Revenue
67.67
+16.92%
57.88
+59.55%
36.27
-30.40%
52.12
Operating Expense
508.66
-14.10%
592.14
+7.36%
551.57
+8.09%
510.29
Research And Development
388.86
-16.61%
466.31
+7.18%
435.07
+3.59%
419.98
Selling General And Administration
119.80
-4.79%
125.83
+8.01%
116.50
+29.00%
90.31
General And Administrative Expense
119.80
-4.79%
125.83
+8.01%
116.50
+29.00%
90.31
Other Gand A
119.80
-4.79%
125.83
+8.01%
116.50
+29.00%
90.31
Total Expenses
508.66
-14.10%
592.14
+7.36%
551.57
+8.09%
510.29
Operating Income
-440.99
+17.46%
-534.26
-3.68%
-515.29
-12.47%
-458.16
Total Operating Income As Reported
-440.99
+17.46%
-534.26
-3.68%
-515.29
-12.47%
-458.16
EBITDA
-425.07
+18.88%
-523.98
-3.49%
-506.31
-12.37%
-450.59
Normalized EBITDA
-424.17
+13.68%
-491.41
+2.92%
-506.21
-15.81%
-437.11
Reconciled Depreciation
15.92
+54.82%
10.29
+14.58%
8.98
+18.54%
7.57
EBIT
-440.99
+17.46%
-534.26
-3.68%
-515.29
-12.47%
-458.16
Total Unusual Items
-0.90
+97.24%
-32.56
-32465.00%
-0.10
+99.26%
-13.48
Total Unusual Items Excluding Goodwill
-0.90
+97.24%
-32.56
-32465.00%
-0.10
+99.26%
-13.48
Special Income Charges
0.00
0.00
+100.00%
-0.10
+99.26%
-13.48
Restructuring And Mergern Acquisition
0.00
0.00
-100.00%
0.10
-99.26%
13.48
Net Income
-412.69
+20.49%
-519.02
-7.86%
-481.19
-1.48%
-474.19
Pretax Income
-412.69
+20.49%
-519.02
-7.86%
-481.19
-1.48%
-474.19
Net Non Operating Interest Income Expense
29.20
-38.93%
47.81
-4.06%
49.83
+483.38%
8.54
Net Interest Income
29.20
-38.93%
47.81
-4.06%
49.83
+483.38%
8.54
Interest Income Non Operating
29.20
-38.93%
47.81
-4.06%
49.83
+483.38%
8.54
Interest Income
29.20
-38.93%
47.81
-4.06%
49.83
+483.38%
8.54
Other Income Expense
-0.90
+97.24%
-32.56
-106.99%
-15.73
+35.95%
-24.56
Gain On Sale Of Security
-0.90
+97.24%
-32.56
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-412.69
+20.49%
-519.02
-7.86%
-481.19
-1.48%
-474.19
Net Income From Continuing Operation Net Minority Interest
-412.69
+20.49%
-519.02
-7.86%
-481.19
-1.48%
-474.19
Net Income From Continuing And Discontinued Operation
-412.69
+20.49%
-519.02
-7.86%
-481.19
-1.48%
-474.19
Net Income Continuous Operations
-412.69
+20.49%
-519.02
-7.86%
-481.19
-1.48%
-474.19
Normalized Income
-411.80
+15.35%
-486.46
-1.11%
-481.09
-4.43%
-460.70
Net Income Common Stockholders
-412.69
+20.49%
-519.02
-7.86%
-481.19
-1.48%
-474.19
Diluted EPS
-3.81
+27.43%
-5.25
+3.14%
-5.42
+12.01%
-6.16
Basic EPS
-3.81
+27.43%
-5.25
+3.14%
-5.42
+12.01%
-6.16
Basic Average Shares
108.38
+9.64%
98.85
+11.35%
88.77
+15.33%
76.97
Diluted Average Shares
108.38
+9.64%
98.85
+11.35%
88.77
+15.33%
76.97
Diluted NI Availto Com Stockholders
-412.69
+20.49%
-519.02
-7.86%
-481.19
-1.48%
-474.19
Earnings From Equity Interest
0.00
0.00
+100.00%
-15.63
-41.10%
-11.08
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
842.13
-29.29%
1,191.02
-8.45%
1,300.98
-14.42%
1,520.11
Current Assets
527.71
-17.53%
639.86
-35.91%
998.33
-17.95%
1,216.80
Cash Cash Equivalents And Short Term Investments
449.88
-25.21%
601.51
-34.06%
912.22
-23.51%
1,192.62
Cash And Cash Equivalents
155.46
-17.82%
189.18
-16.57%
226.75
-56.69%
523.51
Other Short Term Investments
294.42
-28.60%
412.33
-39.85%
685.48
+2.44%
669.12
Receivables
9.47
+11.17%
8.52
-76.64%
36.46
+867.52%
3.77
Accounts Receivable
9.47
+11.17%
8.52
-76.64%
36.46
+867.52%
3.77
Prepaid Assets
—
—
—
—
Other Current Assets
68.36
+129.15%
29.83
-39.92%
49.65
+143.30%
20.41
Total Non Current Assets
314.42
-42.95%
551.15
+82.11%
302.65
-0.22%
303.32
Net PPE
123.63
-49.88%
246.67
+66.52%
148.13
-7.99%
161.00
Gross PPE
182.23
-38.51%
296.36
+57.64%
188.00
-3.19%
194.20
Accumulated Depreciation
-58.61
-17.94%
-49.69
-24.66%
-39.86
-20.07%
-33.20
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
5.21
-5.62%
5.52
+0.04%
5.52
-10.19%
6.14
Other Properties
173.82
-39.57%
287.65
+60.39%
179.34
-3.05%
184.99
Leases
3.20
+0.00%
3.20
+2.07%
3.13
+2.22%
3.07
Investments And Advances
190.79
-37.34%
304.48
+97.06%
154.51
+8.57%
142.32
Long Term Equity Investment
—
0.00
-100.00%
11.77
-63.75%
32.45
Other Investments
35.54
-19.71%
44.26
+3.22%
42.88
+5.81%
40.53
Total Liabilities Net Minority Interest
170.73
-46.49%
319.06
+27.21%
250.81
-11.85%
284.53
Current Liabilities
103.88
-6.29%
110.85
-3.78%
115.21
-8.97%
126.55
Payables And Accrued Expenses
47.04
+2.56%
45.87
-4.15%
47.85
+8.14%
44.25
Payables
20.25
+38.82%
14.59
+95.77%
7.45
+44.59%
5.15
Accounts Payable
20.25
+38.82%
14.59
+95.77%
7.45
+44.59%
5.15
Current Accrued Expenses
26.79
-14.35%
31.28
-22.58%
40.40
+3.34%
39.10
Pensionand Other Post Retirement Benefit Plans Current
23.07
-4.17%
24.07
-9.54%
26.61
+22.21%
21.78
Current Debt And Capital Lease Obligation
26.48
+30.79%
20.25
+8.86%
18.60
+11.47%
16.68
Current Capital Lease Obligation
26.48
+30.79%
20.25
+8.86%
18.60
+11.47%
16.68
Current Deferred Liabilities
7.29
-64.72%
20.66
-6.68%
22.14
-49.50%
43.84
Current Deferred Revenue
7.29
-64.72%
20.66
-6.68%
22.14
-49.50%
43.84
Total Non Current Liabilities Net Minority Interest
66.85
-67.89%
208.21
+53.55%
135.60
-14.16%
157.98
Long Term Debt And Capital Lease Obligation
66.85
-64.81%
189.95
+96.34%
96.75
-15.15%
114.02
Long Term Capital Lease Obligation
66.85
-64.81%
189.95
+96.34%
96.75
-15.15%
114.02
Non Current Deferred Liabilities
0.00
-100.00%
18.26
-53.01%
38.85
+94.93%
19.93
Non Current Deferred Revenue
0.00
-100.00%
18.26
-53.01%
38.85
+94.93%
19.93
Other Non Current Liabilities
—
—
—
24.03
Stockholders Equity
671.39
-23.00%
871.96
-16.97%
1,050.17
-15.01%
1,235.58
Common Stock Equity
671.39
-23.00%
871.96
-16.97%
1,050.17
-15.01%
1,235.58
Capital Stock
0.01
+20.00%
0.01
+11.11%
0.01
+0.00%
0.01
Common Stock
0.01
+20.00%
0.01
+11.11%
0.01
+0.00%
0.01
Share Issued
116.32
+14.00%
102.03
+9.71%
93.00
+6.77%
87.10
Ordinary Shares Number
116.32
+14.00%
102.03
+9.71%
93.00
+6.77%
87.10
Additional Paid In Capital
3,260.44
+6.94%
3,048.74
+12.47%
2,710.80
+12.01%
2,420.22
Retained Earnings
-2,590.09
-18.95%
-2,177.40
-31.30%
-1,658.38
-40.88%
-1,177.19
Gains Losses Not Affecting Retained Earnings
1.03
+70.58%
0.60
+126.79%
-2.26
+69.74%
-7.46
Other Equity Adjustments
1.03
+70.58%
0.60
+126.79%
-2.26
+69.74%
-7.46
Total Equity Gross Minority Interest
671.39
-23.00%
871.96
-16.97%
1,050.17
-15.01%
1,235.58
Total Capitalization
671.39
-23.00%
871.96
-16.97%
1,050.17
-15.01%
1,235.58
Working Capital
423.83
-19.88%
529.01
-40.10%
883.12
-19.00%
1,090.24
Invested Capital
671.39
-23.00%
871.96
-16.97%
1,050.17
-15.01%
1,235.58
Total Debt
93.33
-55.60%
210.20
+82.23%
115.35
-11.75%
130.70
Capital Lease Obligations
93.33
-55.60%
210.20
+82.23%
115.35
-11.75%
130.70
Net Tangible Assets
671.39
-23.00%
871.96
-16.97%
1,050.17
-15.01%
1,235.58
Tangible Book Value
671.39
-23.00%
871.96
-16.97%
1,050.17
-15.01%
1,235.58
Available For Sale Securities
155.25
-40.34%
260.21
+160.57%
99.86
+44.02%
69.34
Investmentin Financial Assets
155.25
-40.34%
260.21
+160.57%
99.86
+44.02%
69.34
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-394.74
-13.14%
-348.88
+11.47%
-394.09
-18.24%
-333.29
Cash Flow From Continuing Operating Activities
-394.74
-13.14%
-348.88
+11.47%
-394.09
-18.24%
-333.29
Net Income From Continuing Operations
-412.69
+20.49%
-519.02
-7.86%
-481.19
-1.48%
-474.19
Depreciation Amortization Depletion
15.92
+54.82%
10.29
+14.58%
8.98
+18.54%
7.57
Depreciation
15.92
+54.82%
10.29
+14.58%
8.98
—
Depreciation And Amortization
15.92
+54.82%
10.29
+14.58%
8.98
+18.54%
7.57
Other Non Cash Items
—
-20.97
-411.82%
6.72
-91.69%
80.88
Stock Based Compensation
80.22
-48.00%
154.27
+15.09%
134.05
+46.66%
91.40
Operating Gains Losses
0.53
+793.42%
-0.08
-100.48%
15.71
+43.86%
10.92
Unrealized Gain Loss On Investment Securities
0.90
-97.24%
32.56
0.00
0.00
Gain Loss On Sale Of PPE
0.53
+793.42%
-0.08
-205.56%
0.07
+144.44%
-0.16
Change In Working Capital
-73.75
-720.91%
11.88
+122.65%
-52.45
+2.64%
-53.87
Change In Receivables
-0.95
-103.40%
27.94
+185.47%
-32.69
-1781.87%
-1.74
Changes In Account Receivables
-0.95
-103.40%
27.94
+185.47%
-32.69
-1781.87%
-1.74
Change In Prepaid Assets
-26.35
-608.33%
5.18
+119.08%
-27.17
-1157.78%
-2.16
Change In Payables And Accrued Expense
0.72
+119.98%
-3.58
-141.93%
8.55
-24.64%
11.34
Change In Accrued Expense
-5.27
+49.23%
-10.38
-272.36%
6.02
-62.17%
15.92
Change In Payable
5.99
-11.96%
6.80
+169.63%
2.52
+155.02%
-4.58
Change In Account Payable
5.99
-11.96%
6.80
+169.63%
2.52
+155.02%
-4.58
Change In Other Working Capital
-28.11
-27.34%
-22.08
-694.67%
-2.78
+95.62%
-63.46
Change In Other Current Assets
35.90
+60.38%
22.38
+22.28%
18.30
+52.15%
12.03
Change In Other Current Liabilities
-54.95
-205.81%
-17.97
-7.81%
-16.67
-68.67%
-9.88
Investing Cash Flow
228.03
+81.60%
125.57
+500.57%
-31.35
-119.55%
160.31
Cash Flow From Continuing Investing Activities
228.03
+81.60%
125.57
+500.57%
-31.35
-119.55%
160.31
Net PPE Purchase And Sale
-1.13
+80.46%
-5.78
+58.68%
-13.98
-4.30%
-13.41
Purchase Of PPE
-1.13
+80.46%
-5.78
+58.68%
-13.98
-3.15%
-13.56
Sale Of PPE
—
0.00
0.00
-100.00%
0.15
Capital Expenditure
-1.13
+80.46%
-5.78
+58.68%
-13.98
+76.05%
-58.39
Net Investment Purchase And Sale
229.16
+74.47%
131.34
+856.51%
-17.36
-107.94%
218.55
Purchase Of Investment
-322.51
+65.53%
-935.57
-3.44%
-904.46
-110.82%
-429.03
Sale Of Investment
551.67
-48.29%
1,066.92
+20.27%
887.10
+36.99%
647.58
Net Business Purchase And Sale
—
—
0.00
0.00
Purchase Of Business
—
—
0.00
0.00
Net Intangibles Purchase And Sale
—
0.00
0.00
+100.00%
-44.83
Purchase Of Intangibles
—
0.00
0.00
+100.00%
-44.83
Financing Cash Flow
131.49
-29.21%
185.75
+42.53%
130.32
-77.64%
582.96
Cash Flow From Continuing Financing Activities
131.49
-29.21%
185.75
+42.53%
130.32
-77.64%
582.96
Net Common Stock Issuance
128.18
-27.54%
176.90
+47.67%
119.80
-78.83%
565.79
Proceeds From Stock Option Exercised
3.31
-62.58%
8.85
-15.96%
10.53
-38.67%
17.17
Changes In Cash
-35.22
+6.25%
-37.57
+87.27%
-295.11
-171.98%
409.98
Beginning Cash Position
202.79
-15.63%
240.35
-55.11%
535.46
+326.71%
125.49
End Cash Position
167.57
-17.37%
202.79
-15.63%
240.35
-55.11%
535.46
Free Cash Flow
-395.87
-11.62%
-354.66
+13.09%
-408.07
-4.19%
-391.68
Amortization Of Securities
-5.86
+67.12%
-17.82
+31.20%
-25.90
-746.94%
4.00
Common Stock Issuance
128.18
-27.54%
176.90
+47.67%
119.80
-78.83%
565.79
Earnings Losses From Equity Investments
0.00
0.00
-100.00%
15.63
+41.10%
11.08
Issuance Of Capital Stock
128.18
-27.54%
176.90
+47.67%
119.80
-78.83%
565.79
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category